Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.

ABSTRACT:

Background

Ovarian cancer (OC) is one of the most malignant gynecological tumors, associated with excess death rate (50-60%) in ovarian cancer patients. Particularly, among newly occurred ovarian cancer patients, 70% of clinical cases are diagnosed at the advanced stage, which definitely delay the timely treatment and lead to high mortality rate within 5 years post diagnosis. Therefore, identification of sensitive gene markers, as well as development of reliable genetic diagnosis, are important for the early detection and precise therapy for OC patients. This study aims to identify novel genetic mutations and develop a feasible clinical approach for early OC diagnosis.

Methods

The OC tissue-derived DNA sample was acquired from 31 OC patients, and the somatic gene mutations w

SUBMITTER: Zhang L 

PROVIDER: S-EPMC6381667 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature